Annual Gross Margin
N/A
31 December 2023
Summary:
Adaptimmune Therapeutics annual gross profit margin is not available.ADAP Gross Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ADAP Gross Margin Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | - | - |
| 5 y5 years | - | - |
ADAP Gross Margin High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time |
Adaptimmune Therapeutics Gross Margin History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | 93.05%(+0.2%) | - |
| Dec 2021 | 92.85%(-2.2%) | - |
| Dec 2020 | 94.92%(+1.1%) | - |
| Dec 2019 | 93.91%(+20.6%) | - |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | 77.88%(+4.5%) | - |
| Dec 2017 | 74.54%(-1.5%) | - |
| Dec 2016 | 75.70%(-0.8%) | - |
| Dec 2015 | 76.30%(+0.2%) | - |
| Dec 2013 | 76.14% | - |
FAQ
- What is the all time high annual gross margin for Adaptimmune Therapeutics?
What is the all time high annual gross margin for Adaptimmune Therapeutics?
Adaptimmune Therapeutics all-time high annual gross profit margin is 94.92%